Skip to main content
. 2009 Jun 26;8:24. doi: 10.1186/1476-511X-8-24

Table 2.

Clinical characteristics of the main group (separated in men and women), total cases and controls

Men
n = 41
Women
n = 39
P Total cases
n = 80
Controls
n = 11
p*
Age (years) 33.5(11.5) 55.0(11.0) < 0.01 43.0(24.0) 54.0(31.0) 0.03
BMI (kg/m2) 24.7(3.5) 24.3(4.5) 0.25 24.4(4.0) 25.6(2.0) 0.09
Waist (cm) 93.0(14.0) 78.5(13.0) < 0.01 85.0(17.0) 93.0(26.5) 0.26
TC (mg/dl) 292.0(70.5) 319.0(45.0) 0.01 313.5(56.3) 215.0(39.0) < 0.01
TG0 (mg/dl) 110.0(90.5) 99.0(83.0) 0.53 105.5(85.0) 68.0(33.0) < 0.01
TG2 (mg/dl) 206.0(129.3) 158.0(131.8) 0.20 174.0(119.0) 108.0(53.8) < 0.01
TG4 (mg/dl) 245.0(162.5) 195.0(142.5) 0.12 220.0(160.5) 134.0(52.0) < 0.01
TG6 (mg/dl) 203.0(166.5) 165.0(136.0) 0.40 173.0(171.0) 140.0(63.0) 0.01
TG8 (mg/dl) 157.0(105.0) 134.0(111.0) 0.77 139.5(107.0) 87.0(68.0) 0.02
TG AUC (mg/dl/h) 1568.1(1225.7) 1360.6(809.0) 0.16 1407.9(995.5) 920.8(436.0) < 0.01
TG i-AUC (mg/dl/h) 604.6(630.8) 521.9(420.2) 0.08 564.5(483.8) 346.5(131.7) 0.03
HDL (mg/dl) 40.0(14.5) 55.0(23.0) < 0.01 48.0(18.5) 47.0(12.0) 0.26
LDL (mg/dl) 231.0(61.0) 238.0(45.0) 0.17 232.0(58.8) 135.0(29.0) < 0.01
Apo AI (mg/dl) 132.0(29.3) 158.4(32.0) < 0.01 145.5(40.7) 144.0(31.8) 0.22
Apo B (mg/dl) 153.0(32.5) 162.5(34.1) 0.27 156.9(35.0) 101.0(19.5) < 0.01
Lp (a) (mg/dl) 16.0(15.1) 15.9(30.5) 0.23 16.0(20.3) 21.5(31.4) 0.69
Glu (mg/dl) 86.0(14.3) 90.0(17.0) 0.27 87.5(15.0) 81.5(12.8) 0.03
TaqIB allele frequency n (%)
B1 43 (52.4) 45 (57.7) 0.50 88 (55.0) 7 (35.0) 0.08
B2 39 (47.6) 33 (42.3) 72 (45.0) 13 (65.0)
I405V allele frequency n (%)
I 54 (65.9) 50 (64.1) 0.82 104 (65.0) 16 (72.7) 0.43
V 28 (34.1) 28 (35.9) 56 (35.0) 6 (27.3)
S447X allele frequency n (%)
S 75 (91.5) 69 (88.5) 0.53 144 (90.0) 18 (81.8) 0.26
X 7 (8.5) 9 (11.5) 16 (10.0) 4 (18.2)

Data are presented as medians (interquartile ranges). BMI: body mass index, TC: total cholesterol, TG: triglycerides, AUC: area under the curve, i-AUC: incremental AUC, HDL: high density lipoprotein cholesterol, LDL: low density lipoprotein cholesterol, Apo A: apolipoprotein A, Apo B: apolipoprotein B, Lp (a): lipoprotein (a), Glu: glucose, hFH: heterozygotes for familial hypercholesterolaemia.

*: All comparisons between cases and controls are age-adjusted.